We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Ovarian Cell Hormone Predicts Onset of Menopause

By LabMedica International staff writers
Posted on 06 Jul 2010
Levels of a hormone, produced by cells in the ovary, can be used to predict when a woman's menopause will begin. More...


A hormonal blood test can accurately predict at what age a woman's reproductive status will change. Different quantities of the hormone in the blood can be used to assess when the permanent cessation of ovarian function will occur.

Scientists at the Shahid Beheshti University of Medical Sciences (Tehran, Iran) have measured the anti-Mullerian Hormone (AMH) concentration in women enrolled in a study since 1998. AMH controls the development of follicles in the ovaries, from which oocytes (eggs) develop and it has been suggested that AMH could be used for measuring ovarian function. Blood samples were taken at three yearly intervals, and they also collected information on the women's socioeconomic background and reproductive histories.

The results from the study enabled the scientists to make a more realistic assessment of women's reproductive status many years before they reach menopause. For example, if a 20-year-old woman has a concentration of serum AMH of 2.8 ng/mL they estimate that she will become menopausal between 35 to 38 years old. The statistical model used to correlate AMH levels at different ages could predict if women were likely to have an early menopause (before the age of 45). They found that AMH levels of 4.1 ng/mL or less predicted early menopause in 20-year-olds, AMH levels of 3.3 ng/mL predicted it in 25-year-olds, and AMH levels of 2.4 ng/mL predicted it in 30-year-olds. In contrast, AMH levels of at least 4.5 ng/mL at the age of 20, 3.8 ngl/mL at 25 and 2.9 ng/mL at 30 all predicted an age at menopause of over 50 years old. The results of the study were presented at the annual meeting of European Society of Human Reproduction and Embryology held in June, 2010 in Rome, Italy.

The estimates of ages at menopause based on AMH levels are of sufficient validity to guide medical practitioners in their day-to-day practice, so that they can help women with their family planning.

Related Links:
European Society of Human Reproduction and Embryology



Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
PSA Assay
CanAg PSA EIA
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.